These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15941215)

  • 21. Highly efficient catalyst systems using iron complexes with a tetradentate PNNP ligand for the asymmetric hydrogenation of polar bonds.
    Sui-Seng C; Freutel F; Lough AJ; Morris RH
    Angew Chem Int Ed Engl; 2008; 47(5):940-3. PubMed ID: 18098264
    [No Abstract]   [Full Text] [Related]  

  • 22. Helicoverpa zea CYP6B8 and CYP321A1: different molecular solutions to the problem of metabolizing plant toxins and insecticides.
    Rupasinghe SG; Wen Z; Chiu TL; Schuler MA
    Protein Eng Des Sel; 2007 Dec; 20(12):615-24. PubMed ID: 18065401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular perspective: cytochrome P450.
    Goodsell DS
    Stem Cells; 2001; 19(3):263-4. PubMed ID: 11359952
    [No Abstract]   [Full Text] [Related]  

  • 24. Preferential hydroxylation over epoxidation catalysis by a horseradish peroxidase mutant: a cytochrome P450 mimic.
    de Visser SP
    J Phys Chem B; 2007 Oct; 111(42):12299-302. PubMed ID: 17914801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electronic structure of compound I in human isoforms of cytochrome P450 from QM/MM modeling.
    Bathelt CM; Zurek J; Mulholland AJ; Harvey JN
    J Am Chem Soc; 2005 Sep; 127(37):12900-8. PubMed ID: 16159284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of cytochrome P450 MoxA from Nonomuraea recticatena (CYP105).
    Yasutake Y; Imoto N; Fujii Y; Fujii T; Arisawa A; Tamura T
    Biochem Biophys Res Commun; 2007 Oct; 361(4):876-82. PubMed ID: 17679139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrafast heme dynamics in ferrous versus ferric cytochrome c studied by time-resolved resonance Raman and transient absorption spectroscopy.
    Negrerie M; Cianetti S; Vos MH; Martin JL; Kruglik SG
    J Phys Chem B; 2006 Jun; 110(25):12766-81. PubMed ID: 16800612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward autonomously operating molecular machines driven by transition-metal catalyst.
    Tanaka K; Kinbara K
    Mol Biosyst; 2008 Jun; 4(6):512-4. PubMed ID: 18493646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations into the analysis and modeling of the cytochrome P450 cycle.
    Wang Y; Li Y; Li Y; Ma X; Yang S; Yang L
    J Phys Chem B; 2006 May; 110(20):10139-43. PubMed ID: 16706475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic C-H amination: a reaction now accessible to engineered natural enzymes.
    Mahy JP; Ciesielski J; Dauban P
    Angew Chem Int Ed Engl; 2014 Jul; 53(27):6862-4. PubMed ID: 24895319
    [No Abstract]   [Full Text] [Related]  

  • 33. Iron(III) complexes of certain meridionally coordinating tridentate ligands as models for non-heme iron enzymes: the role of carboxylate coordination.
    Dhanalakshmi T; Bhuvaneshwari M; Palaniandavar M
    J Inorg Biochem; 2006 Sep; 100(9):1527-34. PubMed ID: 16814389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "somersault" mechanism for the p-450 hydroxylation of hydrocarbons. The intervention of transient inverted metastable hydroperoxides.
    Bach RD; Dmitrenko O
    J Am Chem Soc; 2006 Feb; 128(5):1474-88. PubMed ID: 16448118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego.
    Fantuzzi A; Meharenna YT; Briscoe PB; Sassone C; Borgia B; Gilardi G
    Chem Commun (Camb); 2006 Mar; (12):1289-91. PubMed ID: 16538250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrochemical generation of a high-valent state of cytochrome P450.
    Udit AK; Hill MG; Gray HB
    J Inorg Biochem; 2006 Apr; 100(4):519-23. PubMed ID: 16504300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QM/MM modeling of compound I active species in cytochrome P450, cytochrome C peroxidase, and ascorbate peroxidase.
    Harvey JN; Bathelt CM; Mulholland AJ
    J Comput Chem; 2006 Sep; 27(12):1352-62. PubMed ID: 16788912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different binding modes of two flaviolin substrate molecules in cytochrome P450 158A1 (CYP158A1) compared to CYP158A2.
    Zhao B; Lamb DC; Lei L; Kelly SL; Yuan H; Hachey DL; Waterman MR
    Biochemistry; 2007 Jul; 46(30):8725-33. PubMed ID: 17614370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directing spatial disposition of ferrocene around homoadenine tetrads.
    Kumar J; Purohit CS; Verma S
    Chem Commun (Camb); 2008 Jun; (22):2526-8. PubMed ID: 18506232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electron paramagnetic resonance analyses of biotransformation reactions with cytochrome P-450 immobilized on mesoporous molecular sieves.
    Rosales-Hernández M; Kispert L; Torres-Ramírez E; Ramírez-Rosales D; Zamorano-Ulloa R; Trujillo-Ferrara J
    Biotechnol Lett; 2007 Jun; 29(6):919-24. PubMed ID: 17450324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.